Skip to main content

Timing of intubation in COVID-19: Not just location, location, location?

We read with interest the paper by Papoutsi et. al. in which they synthesise the available evidence for early versus late intubation for COVID-19-related respiratory failure [1]. While many studies have reported on predictors of mortality in severe COVID-19, the majority of these factors are not modifiable. The selection for and timing of the escalation to mechanical ventilation are modifiable and of particular relevance in resource-constrained settings to optimise the use of ICU resources [2].

Differentiating between the timing of intubation once admitted to ICU for 24 h (the primary definition in their study) or intubation based on a trial of non-invasive mechanical support (their secondary definition) has vastly different implications. At our institution, a decision was made to reserve and expand ICU services only for COVID-19 patients requiring invasive mechanical ventilation, and to offer high-flow nasal oxygen (HFNO) in a non-critical care ward-based environment. Patients coming to the ICU were all intubated outside of the ICU having had a trial of HFNO [3]. Our patients would be considered early intubations by the primary definition, and late intubations in the secondary analysis.

In our cohort of 293 patients, we had 52.7% survival without mechanical ventilation (with a median P/F ratio of 68 on non-rebreather support at initiation of HFNO) and a median duration of HFNO support of 6 days in survivors, and 2 days in non-survivors. Unfortunately, this result needs to be balanced against the initial poor outcomes (8% survival) of those patients who progressed to need invasive mechanical ventilation [4]. We would therefore caution against a definition of early intubation that is based on the patient accessing a physical location (ICU) or level of support (HFNO) without quantifying the severity of the patient’s underlying respiratory failure or need for other organ support.

It is essential that studies provide consistent information on the severity of illness and information is given on context and setting when reporting studies on mechanical ventilation in COVID-19 pneumonia. We noted that 5 of the 12 studies did not report the SOFA score of the patients at the time of ICU admission and that 6 of the 12 publications analysed required the authors to supply additional information from that published in order to allow this analysis. Understanding the clinical triggers for accessing ICU care, the severity of respiratory failure prior to intubation, and the available resources in a particular setting is key to assessing time-sensitive interventions such as intubation.

Availability of supporting data

Patient data has been previously published and is available on request [4].

References

  1. 1.

    Papoutsi E, Giannakoulis VG, Xourgia E, Routsi C, Kotanidou A, Siempos II. Effect of timing of intubation on clinical outcomes of critically ill patients with COVID-19: a systematic review and meta-analysis of non-randomized cohort studies. Crit Care. 2021;25(1):1–9. https://doi.org/10.1186/s13054-021-03540-6.

    Article  Google Scholar 

  2. 2.

    Morrow BM, Gopalan PD, Joubert I, Paruk F, Pope A. Critical care triage during the COVID-19 pandemic in South Africa: A constitutional imperative! SAMJ S Afr Med J. 2020;110(12):1176–9. https://doi.org/10.7196/SAMJ.2020.v110i12.15411.

    CAS  Article  PubMed  Google Scholar 

  3. 3.

    Mendelson M, Boloko L, Boutall A, Cairncross L, Calligaro G, Coccia C, Dave JA, De Villiers M, Dlamini S, Frankenfeld P, Gina P. Clinical management of COVID-19: experiences of the COVID-19 epidemic from Groote Schuur Hospital, Cape Town, South Africa. SAMJ S Afr Med J. 2020. https://doi.org/10.7196/SAMJ.2020.v110i10.15157.

    Article  PubMed  Google Scholar 

  4. 4.

    Calligaro GL, Lalla U, Audley G, Gina P, Miller MG, Mendelson M, Dlamini S, Wasserman S, Meintjes G, Peter J, Levin D. The utility of high-flow nasal oxygen for severe COVID-19 pneumonia in a resource-constrained setting: a multi-centre prospective observational study. EClinicalMedicine. 2020;28:100570. https://doi.org/10.1016/j.eclinm.2020.100570.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

There are no acknowledgements to be noted for this letter to the editor.

Funding

The authors received no funding support for this letter to the editor.

Author information

Affiliations

Authors

Contributions

DT and GC are both responsible for writing, revising, and submitting this letter to the editor. All authors read and approved the final manuscript.

Corresponding author

Correspondence to David A. Thomson.

Ethics declarations

Ethical approval and consent to participate

Patient data in this letter has been published [4] under ethically approved protocol from the University of Cape Town and University of Stellenbosch (UCT HREC 295/2020 and SU HREC S20/05/001_COVID-19).

Consent for publication

No individual patient data is presented in this letter to the editor. Consent for publication of the included data was covered under the above ethical approval.

Competing interests

The authors declare they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Thomson, D.A., Calligaro, G.L. Timing of intubation in COVID-19: Not just location, location, location?. Crit Care 25, 193 (2021). https://doi.org/10.1186/s13054-021-03617-2

Download citation